Datasets:
SKT27182
/
NER_processed_data

Dataset card Viewer Files Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
sequence
ner_tags
sequence
NCT02394028
1:35:chronic_disease
human immunodeficiency virus (HIV)
1
[ "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 2, 2, 2, 2, 0, 0 ]
NCT02929069
1:4:chronic_disease,,
HIV sexual risk (≥1 act of condomless anal with a male partner of unknown status or HIV+ status, unless with HIV+ partner with known undetectable viral load)
1
[ "HIV", "sexual", "risk", "(", "≥1", "act", "of", "condomless", "anal", "with", "a", "male", "partner", "of", "unknown", "status", "or", "HIV+", "status", ",", "unless", "with", "HIV+", "partner", "with", "known", "undetectable", "viral", "load", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02303977
110:119:treatment
Patients must be capable of giving informed consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing
1
[ "Patients", "must", "be", "capable", "of", "giving", "informed", "consent", "and", "be", "willing", "and", "able", "to", "comply", "with", "scheduled", "visits", ",", "treatment", "plan", "and", "laboratory", "testing" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT03114319
8:16:chronic_disease
Active diarrhea
1
[ "Active", "diarrhea" ]
[ 0, 2 ]
NCT02592551
9:28:treatment,33:36:cancer,38:70:treatment,74:109:treatment
Planned resectional surgery for MPM [extrapleural pneumonectomy (EPP) or pleurectomy and decortication (P/D)]
1
[ "Planned", "resectional", "surgery", "for", "MPM", "[", "extrapleural", "pneumonectomy", "(", "EPP", ")", "or", "pleurectomy", "and", "decortication", "(", "P/D", ")", "]" ]
[ 0, 1, 1, 0, 3, 0, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0 ]
NCT01238120
63:75:treatment
Patients with a neutropenic episode during the first cycle of chemotherapy or at high risk for a neutropenic episode during future chemotherapy cycles at the treating physicians discretion
1
[ "Patients", "with", "a", "neutropenic", "episode", "during", "the", "first", "cycle", "of", "chemotherapy", "or", "at", "high", "risk", "for", "a", "neutropenic", "episode", "during", "future", "chemotherapy", "cycles", "at", "the", "treating", "physicians", "discretion" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01849146
,18:90:treatment
4 weeks from any investigational (not Food and Drug Administration [FDA]-approved) agents
1
[ "4", "weeks", "from", "any", "investigational", "(", "not", "Food", "and", "Drug", "Administration", "[", "FDA", "]", "-approved", ")", "agents" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT01686373
12:25:treatment
History of brain surgery
1
[ "History", "of", "brain", "surgery" ]
[ 0, 0, 1, 1 ]
NCT02437370
,,,233:243:treatment,
Female subjects of childbearing potential should be willing to use 2 methods of birth control or be surgically sterile, or abstain from heterosexual activity for the course of the study through 120 days after the last dose of study medication; subjects of childbearing potential are those who have not been surgically sterilized or have not been free from menses for > 1 year
1
[ "Female", "subjects", "of", "childbearing", "potential", "should", "be", "willing", "to", "use", "2", "methods", "of", "birth", "control", "or", "be", "surgically", "sterile", ",", "or", "abstain", "from", "heterosexual", "activity", "for", "the", "course", "of", "the", "study", "through", "120", "days", "after", "the", "last", "dose", "of", "study", "medication", ";", "subjects", "of", "childbearing", "potential", "are", "those", "who", "have", "not", "been", "surgically", "sterilized", "or", "have", "not", "been", "free", "from", "menses", "for", ">", "1", "year" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03144245
52:63:treatment
patients with excessive blasts may be treated with hydroxyurea to bring counts down
1
[ "patients", "with", "excessive", "blasts", "may", "be", "treated", "with", "hydroxyurea", "to", "bring", "counts", "down" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02562430
1:20:chronic_disease
psychotic disorders
1
[ "psychotic", "disorders" ]
[ 2, 2 ]
NCT01807897
19:27:chronic_disease,,
Poorly controlled diabetes (HbA1c > 9.0)
1
[ "Poorly", "controlled", "diabetes", "(", "HbA1c", ">", "9.0", ")" ]
[ 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT02793921
14:24:chronic_disease
uncontrolled arrhythmia
1
[ "uncontrolled", "arrhythmia" ]
[ 0, 2 ]
NCT03116685
20:30:treatment,
Patients receiving vitamin B6 must be receiving a stable dose for at least 3 months prior to screening and must not change the dose during the study
1
[ "Patients", "receiving", "vitamin", "B6", "must", "be", "receiving", "a", "stable", "dose", "for", "at", "least", "3", "months", "prior", "to", "screening", "and", "must", "not", "change", "the", "dose", "during", "the", "study" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02078102
,45:67:treatment,79:89:treatment,91:105:treatment,107:125:treatment,131:145:treatment,151:173:treatment,185:197:treatment,201:213:treatment,250:259:treatment
Patients must be at least 4 weeks from last cytotoxic chemotherapy (including alkylating, anthracyclines, epipodophylatoxins, and platinum drugs), or immunomodulatory drugs (including lenalidomide or pomalidomide, or related derivatives) at time of treatment on this protocol
1
[ "Patients", "must", "be", "at", "least", "4", "weeks", "from", "last", "cytotoxic", "chemotherapy", "(", "including", "alkylating", ",", "anthracyclines", ",", "epipodophylatoxins", ",", "and", "platinum", "drugs", ")", ",", "or", "immunomodulatory", "drugs", "(", "including", "lenalidomide", "or", "pomalidomide", ",", "or", "related", "derivatives", ")", "at", "time", "of", "treatment", "on", "this", "protocol" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT03069716
16:26:chronic_disease,28:37:chronic_disease,54:79:chronic_disease,99:136:chronic_disease
Diagnosed with idiopathic, heritable, or associated (connective tissue disease, drugs, or toxins) pulmonary arterial hypertension (PAH) according to World Health Organization consensus recommendations
1
[ "Diagnosed", "with", "idiopathic", ",", "heritable", ",", "or", "associated", "(", "connective", "tissue", "disease", ",", "drugs", ",", "or", "toxins", ")", "pulmonary", "arterial", "hypertension", "(", "PAH", ")", "according", "to", "World", "Health", "Organization", "consensus", "recommendations" ]
[ 0, 0, 2, 0, 2, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02603757
29:41:treatment
Patients who do not undergo chemotherapy
1
[ "Patients", "who", "do", "not", "undergo", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 1 ]
NCT02451215
17:27:cancer
Other low-grade CNS tumors
1
[ "Other", "low-grade", "CNS", "tumors" ]
[ 0, 0, 3, 3 ]
NCT02503722
,,,99:118:treatment
Women under 50 years must be postmenopausal for at least 12 months following the end of exogenous hormonal treatments and with LH and FSH levels in the post-menopausal range for the institution
1
[ "Women", "under", "50", "years", "must", "be", "postmenopausal", "for", "at", "least", "12", "months", "following", "the", "end", "of", "exogenous", "hormonal", "treatments", "and", "with", "LH", "and", "FSH", "levels", "in", "the", "post-menopausal", "range", "for", "the", "institution" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02527421
1:34:treatment,42:63:treatment,65:78:treatment,80:93:treatment
systemic anti-inflammatory agents (e.g., mycophenolate mofetil, sulfasalazine, 6-thioguanine)
1
[ "systemic", "anti-inflammatory", "agents", "(", "e.g.", ",", "mycophenolate", "mofetil", ",", "sulfasalazine", ",", "6-thioguanine", ")" ]
[ 1, 1, 1, 0, 0, 0, 1, 1, 0, 1, 0, 1, 0 ]
NCT00492778
23:35:treatment
Patients who received chemotherapy directed at the present recurrence
1
[ "Patients", "who", "received", "chemotherapy", "directed", "at", "the", "present", "recurrence" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02139436
27:30:treatment
leg muscles responsive to FES
1
[ "leg", "muscles", "responsive", "to", "FES" ]
[ 0, 0, 0, 0, 1 ]
NCT02418195
12:24:chronic_disease
Autoimmune polymyositis
1
[ "Autoimmune", "polymyositis" ]
[ 0, 2 ]
NCT02085941
35:44:treatment,54:63:treatment,65:77:treatment,79:86:treatment
must have sustained all available treatment options (radiation, chemotherapy, surgery) as verified by the Dana Farber Cancer Institute's Head and Neck Tumor Board
1
[ "must", "have", "sustained", "all", "available", "treatment", "options", "(", "radiation", ",", "chemotherapy", ",", "surgery", ")", "as", "verified", "by", "the", "Dana", "Farber", "Cancer", "Institute", "'s", "Head", "and", "Neck", "Tumor", "Board" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01943851
,73:82:treatment
at least 28 days (whichever is longer) following the last dose of study treatment
1
[ "at", "least", "28", "days", "(", "whichever", "is", "longer", ")", "following", "the", "last", "dose", "of", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01757418
25:44:chronic_disease,46:48:chronic_disease,52:76:chronic_disease
Documented diagnosis of sickle cell disease (SS or S-β thalassemia genotype)
1
[ "Documented", "diagnosis", "of", "sickle", "cell", "disease", "(", "SS", "or", "S-β", "thalassemia", "genotype", ")" ]
[ 0, 0, 0, 2, 2, 2, 0, 2, 0, 2, 2, 2, 0 ]
NCT02451553
1:31:treatment,33:42:treatment,46:81:treatment,83:92:treatment,97:108:treatment
Prior treatment with erlotinib, gefitinib or EGFR-blocking monoclonal antibodies (cetuximab and panitumumab)
1
[ "Prior", "treatment", "with", "erlotinib", ",", "gefitinib", "or", "EGFR-blocking", "monoclonal", "antibodies", "(", "cetuximab", "and", "panitumumab", ")" ]
[ 1, 1, 1, 1, 0, 1, 0, 1, 1, 1, 0, 1, 0, 1, 0 ]
NCT02324582
12:46:chronic_disease,
history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies)
1
[ "history", "of", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "(", "HIV", "1/2", "antibodies", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02624258
14:30:chronic_disease
Uncontrolled active infection
1
[ "Uncontrolled", "active", "infection" ]
[ 0, 2, 2 ]
NCT01931202
44:56:allergy_name
history of allergic or adverse reaction to escitalopram
1
[ "history", "of", "allergic", "or", "adverse", "reaction", "to", "escitalopram" ]
[ 0, 0, 0, 0, 0, 0, 0, 4 ]
NCT02203695
25:35:cancer
Currently active second malignancy
1
[ "Currently", "active", "second", "malignancy" ]
[ 0, 0, 0, 3 ]
NCT01703949
,63:75:treatment
Patients must be anticipated to complete at least 2 cycles of chemotherapy on study
1
[ "Patients", "must", "be", "anticipated", "to", "complete", "at", "least", "2", "cycles", "of", "chemotherapy", "on", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT02606396
20:40:chronic_disease
Prior diagnosis of esophageal achalasia
1
[ "Prior", "diagnosis", "of", "esophageal", "achalasia" ]
[ 0, 0, 0, 2, 2 ]
NCT02245841
44:52:chronic_disease
Patients with clear features of an overlap myositis
1
[ "Patients", "with", "clear", "features", "of", "an", "overlap", "myositis" ]
[ 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT03104699
1:45:cancer
basal or squamous cell carcinoma of the skin
1
[ "basal", "or", "squamous", "cell", "carcinoma", "of", "the", "skin" ]
[ 3, 3, 3, 3, 3, 3, 3, 3 ]
NCT01389024
7:51:chronic_disease
Known human immunodeficiency virus (HIV) infection
1
[ "Known", "human", "immunodeficiency", "virus", "(", "HIV", ")", "infection" ]
[ 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02481245
19:33:treatment,35:42:treatment,48:62:treatment
Current use of of MAO Inhibitors, statins, and anticoagulants
1
[ "Current", "use", "of", "of", "MAO", "Inhibitors", ",", "statins", ",", "and", "anticoagulants" ]
[ 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 1 ]
NCT02353728
1:44:treatment,
Treatment with other investigational agents within 30 days of Day 1
1
[ "Treatment", "with", "other", "investigational", "agents", "within", "30", "days", "of", "Day", "1" ]
[ 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02828618
1:17:cancer
liver metastasis or bulky lymph-nodes in the mediastinum in CT chest and abdomen/pelvis
1
[ "liver", "metastasis", "or", "bulky", "lymph-nodes", "in", "the", "mediastinum", "in", "CT", "chest", "and", "abdomen/pelvis" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02724540
1:34:cancer
morphologically progressive tumor by RECIST
1
[ "morphologically", "progressive", "tumor", "by", "RECIST" ]
[ 3, 3, 3, 0, 0 ]
NCT02991651
25:55:treatment
Prior treatment with an EGFR tyrosine kinase inhibitor
1
[ "Prior", "treatment", "with", "an", "EGFR", "tyrosine", "kinase", "inhibitor" ]
[ 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02798458
14:22:chronic_disease,,
Uncontrolled diabetes with a hemoglobin A1C greater than 10
1
[ "Uncontrolled", "diabetes", "with", "a", "hemoglobin", "A1C", "greater", "than", "10" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02358187
58:78:chronic_disease,89:98:treatment,102:127:treatment
Patients must not have a history of, or currently active autoimmune disorders requiring cytotoxic or immunosuppressive therapy, or autoimmune disorders with visceral involvement
1
[ "Patients", "must", "not", "have", "a", "history", "of", ",", "or", "currently", "active", "autoimmune", "disorders", "requiring", "cytotoxic", "or", "immunosuppressive", "therapy", ",", "or", "autoimmune", "disorders", "with", "visceral", "involvement" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02977468
,,,176:186:treatment
Female subjects of childbearing potential must be willing to use an adequate method of contraception for the course of the study through 120 days after the last dose of study medication
1
[ "Female", "subjects", "of", "childbearing", "potential", "must", "be", "willing", "to", "use", "an", "adequate", "method", "of", "contraception", "for", "the", "course", "of", "the", "study", "through", "120", "days", "after", "the", "last", "dose", "of", "study", "medication" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02048722
15:40:chronic_disease,
Patients with severe hepatic impairment (Child-Pugh class C)
1
[ "Patients", "with", "severe", "hepatic", "impairment", "(", "Child-Pugh", "class", "C", ")" ]
[ 0, 0, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02556606
23:33:treatment
Patients currently on fluoxetine
1
[ "Patients", "currently", "on", "fluoxetine" ]
[ 0, 0, 0, 1 ]
NCT02680574
1:21:chronic_disease
Severe heart failure at Screening (New York Heart Association Class IV)
1
[ "Severe", "heart", "failure", "at", "Screening", "(", "New", "York", "Heart", "Association", "Class", "IV", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02554253
15:32:chronic_disease,,
pre-operative renal dysfunction including a baseline creatinine equal to or greater than 1.5 mg/dL or requiring dialysis
1
[ "pre-operative", "renal", "dysfunction", "including", "a", "baseline", "creatinine", "equal", "to", "or", "greater", "than", "1.5", "mg/dL", "or", "requiring", "dialysis" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02807272
1:19:chronic_disease,20:44:chronic_disease,56:60:cancer
Myeloproliferative/myelodysplastic syndrome other than CMML
1
[ "Myeloproliferative/myelodysplastic", "syndrome", "other", "than", "CMML" ]
[ 2, 2, 0, 0, 3 ]
NCT02489045
28:52:chronic_disease,
Patients with uncontrolled congestive heart failure (NYHA Class IV)
1
[ "Patients", "with", "uncontrolled", "congestive", "heart", "failure", "(", "NYHA", "Class", "IV", ")" ]
[ 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02389309
36:51:treatment,55:75:treatment,127:139:chronic_disease
patients must not be receiving any anti-thrombotic or anti-platelet agents; patient cannot be on drugs that cause significant prolonged QT (category I drug)
1
[ "patients", "must", "not", "be", "receiving", "any", "anti-thrombotic", "or", "anti-platelet", "agents", ";", "patient", "can", "not", "be", "on", "drugs", "that", "cause", "significant", "prolonged", "QT", "(", "category", "I", "drug", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02639208
79:91:treatment
either in the context of standard treatment or a clinical trial and including chemotherapy
1
[ "either", "in", "the", "context", "of", "standard", "treatment", "or", "a", "clinical", "trial", "and", "including", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02566395
1:29:cancer
Acute lymphoblastic leukemia
1
[ "Acute", "lymphoblastic", "leukemia" ]
[ 3, 3, 3 ]
NCT01366612
7:25:chronic_disease
Known amyloid deposition in heart
1
[ "Known", "amyloid", "deposition", "in", "heart" ]
[ 0, 2, 2, 0, 0 ]
NCT02219555
1:14:chronic_disease
renal failure
1
[ "renal", "failure" ]
[ 2, 2 ]
NCT02638935
,12:27:treatment
Women with breast implants on the same side as the lesion
1
[ "Women", "with", "breast", "implants", "on", "the", "same", "side", "as", "the", "lesion" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT00959140
1:4:cancer,20:29:treatment,34:49:treatment
ALL: Refractory to Induction and salvage therapy
1
[ "ALL", ":", "Refractory", "to", "Induction", "and", "salvage", "therapy" ]
[ 3, 0, 0, 0, 1, 0, 1, 1 ]
NCT02409888
47:80:treatment
individuals reporting current enrollment in a substance abuse treatment program
1
[ "individuals", "reporting", "current", "enrollment", "in", "a", "substance", "abuse", "treatment", "program" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT03158974
28:38:cancer,
Have evidence of an active malignancy or have been immunocompromised within the 60 days prior to Screening
1
[ "Have", "evidence", "of", "an", "active", "malignancy", "or", "have", "been", "immunocompromised", "within", "the", "60", "days", "prior", "to", "Screening" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02538198
15:60:cancer
Patients with progressive or refractory plasma cell myeloma, as defined by International Myeloma Workshop Consensus Panel criteria
1
[ "Patients", "with", "progressive", "or", "refractory", "plasma", "cell", "myeloma", ",", "as", "defined", "by", "International", "Myeloma", "Workshop", "Consensus", "Panel", "criteria" ]
[ 0, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02583893
15:47:chronic_disease
Subjects with uncontrolled high blood pressure
1
[ "Subjects", "with", "uncontrolled", "high", "blood", "pressure" ]
[ 0, 0, 2, 2, 2, 2 ]
NCT01827384
29:38:treatment,48:62:treatment,83:95:treatment
Patients who have had prior treatment with any PARP inhibitor in combination with temozolomide
1
[ "Patients", "who", "have", "had", "prior", "treatment", "with", "any", "PARP", "inhibitor", "in", "combination", "with", "temozolomide" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 1 ]
NCT02067819
7:27:chronic_disease,110:119:chronic_disease,121:126:chronic_disease,128:138:chronic_disease,164:168:chronic_disease,170:176:chronic_disease,181:214:chronic_disease
Major psychiatric disorder at screening that would preclude full participation in study procedures including psychosis, mania, depression, untreated combined type ADHD, autism and pervasive developmental disorders
1
[ "Major", "psychiatric", "disorder", "at", "screening", "that", "would", "preclude", "full", "participation", "in", "study", "procedures", "including", "psychosis", ",", "mania", ",", "depression", ",", "untreated", "combined", "type", "ADHD", ",", "autism", "and", "pervasive", "developmental", "disorders" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 2, 0, 0, 0, 0, 2, 0, 2, 0, 2, 2, 2 ]
NCT01967238
13:28:chronic_disease,30:42:treatment,46:67:treatment
(either the influenza virus, pneumococcal or meningococcal vaccine)
1
[ "(", "either", "the", "influenza", "virus", ",", "pneumococcal", "or", "meningococcal", "vaccine", ")" ]
[ 0, 0, 0, 2, 2, 0, 1, 0, 1, 1, 0 ]
NCT02931110
1:11:treatment
enoxaparin
1
[ "enoxaparin" ]
[ 1 ]
NCT03056339
13:19:chronic_disease,21:30:chronic_disease,32:37:chronic_disease,48:57:chronic_disease,68:85:treatment
Presence of fungal, bacterial, viral, or other infection requiring IV antimicrobials for management
1
[ "Presence", "of", "fungal", ",", "bacterial", ",", "viral", ",", "or", "other", "infection", "requiring", "IV", "antimicrobials", "for", "management" ]
[ 0, 0, 2, 0, 2, 0, 2, 0, 0, 0, 2, 0, 1, 1, 0, 0 ]
NCT02913430
29:41:treatment
More than one prior line of chemotherapy in the metastatic setting
1
[ "More", "than", "one", "prior", "line", "of", "chemotherapy", "in", "the", "metastatic", "setting" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02274116
1:30:chronic_disease
cardiopulmonary complications
1
[ "cardiopulmonary", "complications" ]
[ 2, 2 ]
NCT01676259
35:47:chronic_disease
History of clinically significant coagulopathy
1
[ "History", "of", "clinically", "significant", "coagulopathy" ]
[ 0, 0, 0, 0, 2 ]
NCT01906385
33:45:chronic_disease,
History or clinical evidence of pancreatitis within 2 years
1
[ "History", "or", "clinical", "evidence", "of", "pancreatitis", "within", "2", "years" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0 ]
NCT02793921
28:41:cancer
Medical clearance by their breast cancer surgeon
1
[ "Medical", "clearance", "by", "their", "breast", "cancer", "surgeon" ]
[ 0, 0, 0, 0, 3, 3, 0 ]
NCT02532543
25:35:treatment
Use of any substance or medication that will influence bone metabolism
1
[ "Use", "of", "any", "substance", "or", "medication", "that", "will", "influence", "bone", "metabolism" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT00929006
1:8:chronic_disease,39:53:chronic_disease,57:73:chronic_disease
Obesity resulting from a well-defined endocrinopathy or genetic syndrome
1
[ "Obesity", "resulting", "from", "a", "well-defined", "endocrinopathy", "or", "genetic", "syndrome" ]
[ 2, 0, 0, 0, 0, 2, 0, 2, 2 ]
NCT02954185
1:20:treatment
Cortisone injection
1
[ "Cortisone", "injection" ]
[ 1, 1 ]
NCT02471430
25:47:chronic_disease
No evidence of clinical coronary heart disease
1
[ "No", "evidence", "of", "clinical", "coronary", "heart", "disease" ]
[ 0, 0, 0, 0, 2, 2, 2 ]
NCT02131597
16:31:cancer,169:185:treatment,210:231:treatment
organ-confined prostate cancer with no evidence of recurrent or progressive disease based on prostate-specific antigen (PSA) values are also eligible for this study if hormonal therapy has been initiated or a radical prostatectomy has been performed
1
[ "organ-confined", "prostate", "cancer", "with", "no", "evidence", "of", "recurrent", "or", "progressive", "disease", "based", "on", "prostate-specific", "antigen", "(", "PSA", ")", "values", "are", "also", "eligible", "for", "this", "study", "if", "hormonal", "therapy", "has", "been", "initiated", "or", "a", "radical", "prostatectomy", "has", "been", "performed" ]
[ 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT03137082
26:54:chronic_disease
Having any other current Axis I psychiatric disorders or medical conditions requiring treatment or medication
1
[ "Having", "any", "other", "current", "Axis", "I", "psychiatric", "disorders", "or", "medical", "conditions", "requiring", "treatment", "or", "medication" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01306019
30:63:treatment,,,
demonstrated requirement for intravenous gamma globulin (IVIG) (significant drop over 3 to 6 weeks between peak and trough IgG levels)
1
[ "demonstrated", "requirement", "for", "intravenous", "gamma", "globulin", "(", "IVIG", ")", "(", "significant", "drop", "over", "3", "to", "6", "weeks", "between", "peak", "and", "trough", "IgG", "levels", ")" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02488967
23:53:chronic_disease
History of documented congestive heart failure (CHF)
1
[ "History", "of", "documented", "congestive", "heart", "failure", "(", "CHF", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT01925131
75:106:allergy_name
Patients with a history of a serious allergic or anaphylactic reaction to humanized monoclonal antibodies are not eligible
1
[ "Patients", "with", "a", "history", "of", "a", "serious", "allergic", "or", "anaphylactic", "reaction", "to", "humanized", "monoclonal", "antibodies", "are", "not", "eligible" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 4, 0, 0, 0 ]
NCT03089125
1:36:chronic_disease
Cognitive or psychiatric conditions prohibiting study consent or participation
1
[ "Cognitive", "or", "psychiatric", "conditions", "prohibiting", "study", "consent", "or", "participation" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02519322
,,87:111:cancer
Patients must have histologically or cytologically confirmed stage IIIB/C or stage IV oligometastatic melanoma
1
[ "Patients", "must", "have", "histologically", "or", "cytologically", "confirmed", "stage", "IIIB/C", "or", "stage", "IV", "oligometastatic", "melanoma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02347891
17:51:treatment,,
Have received a non-biologic investigational agent within 30 days or 5 half-lives of the agent (whichever is longer) prior to Screening
1
[ "Have", "received", "a", "non-biologic", "investigational", "agent", "within", "30", "days", "or", "5", "half-lives", "of", "the", "agent", "(", "whichever", "is", "longer", ")", "prior", "to", "Screening" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00739362
12:25:chronic_disease,37:54:chronic_disease,64:76:chronic_disease
History of HIV infection or ongoing chronic infection (such as tuberculosis)
1
[ "History", "of", "HIV", "infection", "or", "ongoing", "chronic", "infection", "(", "such", "as", "tuberculosis", ")" ]
[ 0, 0, 2, 2, 0, 0, 2, 2, 0, 0, 0, 2, 0 ]
NCT01061515
41:53:treatment
All patients must be consented prior to chemotherapy
1
[ "All", "patients", "must", "be", "consented", "prior", "to", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02514083
1:10:treatment,17:20:cancer,34:56:treatment,58:74:treatment,84:98:treatment,100:121:treatment,127:199:treatment
Treatment-naive CLL indicates no prior anti-CLL therapy. Anti-CLL therapy includes chemotherapies, monoclonal antibodies, and targeted agents with known or reasonably expected anti-leukemic activity
1
[ "Treatment-naive", "CLL", "indicates", "no", "prior", "anti-CLL", "therapy", ".", "Anti-CLL", "therapy", "includes", "chemotherapies", ",", "monoclonal", "antibodies", ",", "and", "targeted", "agents", "with", "known", "or", "reasonably", "expected", "anti-leukemic", "activity" ]
[ 1, 3, 0, 0, 1, 1, 1, 0, 1, 1, 0, 1, 0, 1, 1, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT02159495
139:185:treatment
In the case of a related donor: The identified donor must be the original donor whose stem cells were used for the research participant's allogeneic stem cell transplantation (alloSCT)
1
[ "In", "the", "case", "of", "a", "related", "donor", ":", "The", "identified", "donor", "must", "be", "the", "original", "donor", "whose", "stem", "cells", "were", "used", "for", "the", "research", "participant", "'s", "allogeneic", "stem", "cell", "transplantation", "(", "alloSCT", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0 ]
NCT02639065
,,,,216:225:treatment
Females of childbearing potential and males must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until 12 weeks after treatment discontinuation
1
[ "Females", "of", "childbearing", "potential", "and", "males", "must", "be", "willing", "to", "use", "an", "effective", "method", "of", "contraception", "(", "hormonal", "or", "barrier", "method", "of", "birth", "control", ";", "abstinence", ")", "from", "the", "time", "consent", "is", "signed", "until", "12", "weeks", "after", "treatment", "discontinuation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02926924
10:25:chronic_disease
Previous spine infection
1
[ "Previous", "spine", "infection" ]
[ 0, 2, 2 ]
NCT02857283
23:45:chronic_disease
including significant cardiovascular disease
1
[ "including", "significant", "cardiovascular", "disease" ]
[ 0, 0, 2, 2 ]
NCT01685411
14:48:treatment
eligible for TBI containing preparative regimen
1
[ "eligible", "for", "TBI", "containing", "preparative", "regimen" ]
[ 0, 0, 1, 1, 1, 1 ]
NCT02515110
1:13:treatment,,55:67:treatment,72:85:cancer,106:127:treatment
Radiotherapy must begin within 10 weeks following the last surgery for breast cancer or the last dose of adjuvant chemotherapy
1
[ "Radiotherapy", "must", "begin", "within", "10", "weeks", "following", "the", "last", "surgery", "for", "breast", "cancer", "or", "the", "last", "dose", "of", "adjuvant", "chemotherapy" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 3, 3, 0, 0, 0, 0, 0, 1, 1 ]
NCT02762006
8:26:chronic_disease,84:103:chronic_disease,105:116:chronic_disease,137:171:chronic_disease
active bleeding diathesis including any subject known to have evidence of acute or chronic hepatitis B, hepatitis C (detectable RNA) or human immunodeficiency virus (HIV)
1
[ "active", "bleeding", "diathesis", "including", "any", "subject", "known", "to", "have", "evidence", "of", "acute", "or", "chronic", "hepatitis", "B", ",", "hepatitis", "C", "(", "detectable", "RNA", ")", "or", "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT01648751
10:41:treatment,
Previous bilateral salpingo-oophorectomy (women with 1 ovary will be eligible)
1
[ "Previous", "bilateral", "salpingo-oophorectomy", "(", "women", "with", "1", "ovary", "will", "be", "eligible", ")" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02442102
,49:59:treatment
Patient is not expected to require ≥48 hours of intubation
1
[ "Patient", "is", "not", "expected", "to", "require", "≥48", "hours", "of", "intubation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02535312
92:98:treatment
No studies have been performed to assess potential metabolic and transport interactions of TRC102
1
[ "No", "studies", "have", "been", "performed", "to", "assess", "potential", "metabolic", "and", "transport", "interactions", "of", "TRC102" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02332668
,110:120:treatment
abstain from heterosexual activity for the course of the study through 120 days after the last dose of study medication
1
[ "abstain", "from", "heterosexual", "activity", "for", "the", "course", "of", "the", "study", "through", "120", "days", "after", "the", "last", "dose", "of", "study", "medication" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT00107289
1:24:chronic_disease
grade 3 hearing deficit is acceptable
1
[ "grade", "3", "hearing", "deficit", "is", "acceptable" ]
[ 2, 2, 2, 2, 0, 0 ]
NCT02442635
11:23:treatment
Receiving Chemotherapy
1
[ "Receiving", "Chemotherapy" ]
[ 0, 1 ]
NCT02309580
1:25:treatment
Systemic corticosteroids are permissible in the following circumstances
1
[ "Systemic", "corticosteroids", "are", "permissible", "in", "the", "following", "circumstances" ]
[ 1, 1, 0, 0, 0, 0, 0, 0 ]